
The data were presented today during an oral session at the 66th American Society of Hematology (ASH) Annual Meeting in…
According to IQVIA TM sales data for the 12-month period ending September 2024, the Travatan Z Ophthalmic Solution USP, 0.004%…
If confirmed in clinical settings, this advantage could position ISB 2001 to leapfrog these approved therapies and expedite its path to…
According to the company, the oral presentation will detail results from the dose-escalation portion of the study.
Glenmark made its foray into the dermatology therapy area over four decades ago and has maintained a robust presence in…
Glenmark Pharma has agreed to pay $25 million in six installments over five years and interest on the settlement amount…
Glenmark Pharmaceuticals recorded revenue from operations at Rs 3244.19 crore, up 6.9 per cent as against Rs 3036.07 crore during…
According to the company, this partnership is timely, as many low-and middle-income countries, including India, are experiencing an increasing cancer…
According to IQVIATM sales data for the 12-month period ending March 2024, the Combigan Ophthalmic Solution, 0.2%|0.5% market achieved annual…
Glenmark’s current portfolio consists of 195 products authorized for distribution in the U.S. marketplace and 52 ANDA’s pending approval with…
Glenmark initiated Class II recall of the drug across the US on March 26 this year.
The prevalence of Atopic Dermatitis has been on the rise over the past three decades with an estimated prevalence of…
Harnessing the combined proficiency of over 150 scientists, IGI will leverage the capabilities of its three global centers of innovation.
Envafolimab has obtained two orphan drug designation from the U.S. FDA for advanced biliary tract cancer and soft tissue sarcoma…
In 2015, Glenmark was the first to launch the DPP4 inhibitor, Teneligliptin (Zita Plus and Ziten), followed by a FDC…
As a leader in dermatology, we have actively sought opportunities to leverage our know-how and establish our presence across the…
Glenmark incurred an exceptional cost of 3.25 billion rupees, during the quarter, related to a legal case settlement with the…
According to IQVIA TM sales data for the 12-month period ending September 2023, the Prolixin Tablets, 1 mg, 2.5 mg,…